Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to support a national network of research centers for development of effective and comprehensive medical countermeasures applicable to all subsets of the civilian population in the event of radiological or nuclear emergencies. Applications are sought that propose multidisciplinary basic and translational research to support the development of new medical products that will assess, diagnose, mitigate and/or treat the short-, delayed- and long-term consequences of radiation exposure during and following a radiation public health emergency (e.g. a radiological/nuclear terrorist incident or accident). The goals of this FOA are to: 1) develop new techniques and devices to measure radiation exposure in the human body; 2) follow biomarkers of tissue damage and recovery; and 3) further develop existing (e.g. products in clinical use) as well as novel therapies to minimize tissue damage, hasten tissue recovery, restore normal physiological function, and improve survival.


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): May 31, 2019

RFA-AI-19-012 Expiration Date June 1, 2019

Agency Website

Eligibility Requirements

An individual may serve as PD/PI on only one application to this FOA but may be a Project Leader or Core Leader on more than one application.



Amount Description

Application budgets of up to $1.5 million direct costs per year may be requested for the Individual Administrative Core, Research Projects and Service Cores combined.

Budget requests for the required Consortium-Wide Cores (CCC and OFMC) must be separate from the above $1.5 million direct costs per year and are capped at a combined direct costs of $2.925 million per year.

Direct costs requested for the Centers for Medical Countermeasures Against Radiation Consortium application (including the required Consortium-wide Cores) may not exceed $4.425 million.

Funding Type





Engineering and Physical Sciences
Medical - Basic Science
Medical - Translational

External Deadline

May 31, 2019